Tectonic Therapeutic (TECX) grants options and RSUs to CBO
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Schwabish Marc reported acquisition or exercise transactions in this Form 4 filing.
Tectonic Therapeutic, Inc. Chief Business Officer Marc Schwabish reported receiving new equity awards in the form of stock options and restricted stock units. On March 4, 2026, he was granted 17,750 employee stock options and 19,500 shares of common stock represented by restricted stock units.
The restricted stock units each correspond to one share of common stock and are scheduled to vest in three equal annual installments on March 4, 2027, March 4, 2028, and March 4, 2029, subject to his continued service. The stock options vest in 48 equal monthly installments beginning on April 4, 2026, also conditioned on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Schwabish Marc
Role
Chief Business Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 17,750 | $0.00 | -- |
| Grant/Award | Common Stock | 19,500 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 17,750 shares (Direct);
Common Stock — 45,314 shares (Direct)
Footnotes (1)
- These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of March 4, 2027, March 4, 2028 and March 4, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date. The shares subject to the option vest in 48 equal monthly installments beginning on April 4, 2026, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
FAQ
What insider transaction did Tectonic Therapeutic (TECX) report for Marc Schwabish?
Marc Schwabish, Chief Business Officer of Tectonic Therapeutic, reported equity awards rather than open‑market trades. On March 4, 2026, he acquired 17,750 employee stock options and 19,500 restricted stock units, each RSU representing one share of common stock, subject to future vesting.
How many restricted stock units did Marc Schwabish receive at Tectonic Therapeutic (TECX)?
Marc Schwabish received 19,500 restricted stock units tied to Tectonic Therapeutic common stock. Each RSU represents a contingent right to one share. These units vest in three equal annual installments on March 4, 2027, March 4, 2028, and March 4, 2029, assuming continued service.
What are the vesting terms for Marc Schwabish’s restricted stock units at TECX?
The restricted stock units vest over three years. They are scheduled to vest in three equal annual installments on March 4, 2027, March 4, 2028, and March 4, 2029, and each vesting date requires Marc Schwabish to remain in service with Tectonic Therapeutic.
What stock option grant did Marc Schwabish receive from Tectonic Therapeutic (TECX)?
Marc Schwabish was granted 17,750 employee stock options described as a right to buy Tectonic Therapeutic common stock. These options vest in 48 equal monthly installments beginning on April 4, 2026, with each monthly vesting conditioned on his continued service to the company.
Do Marc Schwabish’s TECX equity awards involve any immediate cash transactions?
The reported transactions show equity awards coded as grants or other acquisitions rather than open‑market purchases. Both the restricted stock units and the employee stock options were granted on March 4, 2026, with no purchase price indicated, and are subject to multi‑year vesting schedules.